Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29,635Revenue $M1,551Net Margin (%)16.3Z-Score19.4
Enterprise Value $M28,265EPS $1.3Operating Margin %34.0F-Score4
P/E(ttm))119Cash Flow Per Share $0.8Pre-tax Margin (%)33.9Higher ROA y-yN
Price/Book12.610-y EBITDA Growth Rate %0Quick Ratio4.9Cash flow > EarningsY
Price/Sales19.35-y EBITDA Growth Rate %52.4Current Ratio5.5Lower Leverage y-yY
Price/Cash Flow115y-y EBITDA Growth Rate %29.8ROA % (ttm)7.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)10.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M196ROI % (ttm)16.0Gross Margin Increase y-yN

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNFrank Sands 2013-09-30 Reduce-0.27%$94.34 - $117.28
($109.83)
$ 149.836%Reduce -10.5%7,540,405
ALXNFrank Sands 2013-03-31 Add0.11%$83.39 - $102.57
($93.13)
$ 149.861%Add 4.23%8,420,336
ALXNJoel Greenblatt 2013-03-31 Sold Out -0.07%$83.39 - $102.57
($93.13)
$ 149.861%Sold Out0
ALXNJoel Greenblatt 2012-12-31 Buy 0.07%$87.97 - $118.15
($98.27)
$ 149.852%New holding, 12977 sh.12,977
ALXNFrank Sands 2012-06-30 Add0.27%$83.74 - $98.82
($91.04)
$ 149.864%Add 6.43%9,739,804
ALXNGeorge Soros 2012-06-30 Sold Out -0.07%$83.74 - $98.82
($91.04)
$ 149.864%Sold Out0
ALXNGeorge Soros 2012-03-31 Buy 0.07%$70.29 - $94.31
($75.85)
$ 149.898%New holding, 50000 sh.50,000
ALXNJoel Greenblatt 2011-09-30 Sold Out -0.0882%$47.81 - $66.99
($56.19)
$ 149.8167%Sold Out0
ALXNJoel Greenblatt 2011-06-30 Buy 0.09%$44.61 - $52.195
($47.91)
$ 149.8213%New holding, 13417 sh.13,417
ALXNGeorge Soros 2011-06-30 Sold Out $44.61 - $52.195
($47.91)
$ 149.8213%Sold Out0
ALXNGeorge Soros 2011-03-31 Add$20.14 - $24.93
($22.51)
$ 149.8566%Add 90.48%4,000
ALXNGeorge Soros 2010-12-31 Reduce$31.78 - $41.17
($36.65)
$ 149.8309%Reduce -87.61%4,200
ALXNGeorge Soros 2010-09-30 Buy 0.03%$24.99 - $32.49
($28.22)
$ 149.8431%New holding, 33900 sh.33,900
ALXNGeorge Soros 2010-06-30 Sold Out -0.17%$24.31 - $28.34
($26.54)
$ 149.8464%Sold Out0
ALXNGeorge Soros 2010-03-31 Add0.06%$22.75 - $27.7
($24.88)
$ 149.8502%Add 51.77%214,000
ALXNGeorge Soros 2009-12-31 Buy 0.1%$21.65 - $24.33
($22.8)
$ 149.8557%New holding, 141000 sh.141,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALXN Frank Sands 2013-12-317,370,6013.772.6-2.25%
Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADRI JOSEPH ADirector 2014-03-11Sell60,000$178.61-16.55view
Carmichael ClareSVP, Chief HR Officer 2014-03-03Sell305$174.77-14.72view
PARVEN ALVIN SDirector 2014-02-11Sell2,471$174.06-14.37view
SQUINTO STEPHEN PEVP, Chief Global Ops. Officer 2014-02-10Sell7,055$158.04-5.69view
Wright Frank JSVP, President Alxn Pharm Intl 2014-02-07Sell1,098$155.57-4.19view
BELL LEONARDCEO 2014-02-07Sell4,620$155.56-4.18view
Carmichael ClareSVP, Chief HR Officer 2014-02-07Sell1,006$155.56-4.18view
Hallal DavidEVP, Chief Commercial Officer 2014-02-07Sell1,620$155.57-4.19view
Moriarty John BSVP & General Counsel 2014-02-07Sell1,036$155.6-4.21view
Sinha VikasEVP & CFO 2014-02-07Sell1,620$155.57-4.19view

Press Releases about ALXN :

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Therm Feb 10 2014 
Weekly Insider Sells Highlight: EA, ALXN, AAL, TMO Feb 09 2014 
You Can No Longer Ignore Biotech Feb 07 2014 
Six High-Impact Sells - Viking Global Investors Aug 26 2013 
CEO of Alexion Pharmaceuticals Inc. Leonard Bell Sold 140,000 Shares Aug 19 2013 
Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
fv 107 Apr 01 2013 
Weekly Top Insider Sells: GOOG, KSS, ALXN, and QCOM Sep 03 2012 
Weekly Top Insider Sells: GOOG, YHOO, ALXN, and CTL Jun 04 2012 
Alexion is Betting on Soliris and a Little Charity Mar 06 2012 


Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide